Shu Okamura
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer-related Molecular Pathways
Papers in
-
- Gastrointestinal Tumor Research and Treatment 8
- Oncology 36
- Colorectal Cancer Surgical Treatments 9
- Colorectal Cancer Treatments and Studies 9
- Cancer-related Molecular Pathways 7
- Co-authors
- Curtis C. HarrisMakoto NagashimaKoh MiuraMasayuki ShisekiS. Perwez HussainPeijun HeMorito MondenHirofumi Arakawa
- Journals
- Gastric Cancer (2 papers)International Journal of Oncology (2 papers)Surgery Today (2 papers)Cancer Science (2 papers)International Journal of Clinical Oncology (2 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Shu Okamura
61 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 97
- Cancer Research 433
- Oncology 600
- Molecular Biology 1.2k
- Biotechnology 96
- Aging 13
Countries citing papers authored by Shu Okamura
This map shows the geographic impact of Shu Okamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Okamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Okamura more than expected).
Fields of papers citing papers by Shu Okamura
This network shows the impact of papers produced by Shu Okamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Okamura. The network helps show where Shu Okamura may publish in the future.
Co-authors
The 25 scholars most cited alongside Shu Okamura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 1 | |
| 5 | 2021 | 16 | |
| 6 | 2021 | 7 | |
| 7 | 2020 | 4 | |
| 8 | 2019 | 12 | |
| 9 | 2014 | 45 | |
| 10 | 2012 | 29 | |
| 11 | 2011 | 3 | |
| 12 | 2011 | 82 | |
| 13 | 2010 | 12 | |
| 14 | 2010 | 45 | |
| 15 | 2008 | 9 | |
| 16 | 2007 | 11 | |
| 17 | p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. | 2003 | 229 |
| 18 | Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. | 2003 | 236 |
| 19 | 2001 | 290 | |
| 20 | 1998 | 7 |
About Shu Okamura
Shu Okamura is a scholar working on Gastroenterology, Oncology, Pulmonary and Respiratory Medicine, Biotechnology and Cancer Research, having authored 72 papers that have together received 1.8k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (20 papers), Metastasis and carcinoma case studies (14 papers), Multiple and Secondary Primary Cancers (11 papers), Colorectal Cancer Surgical Treatments (9 papers), Colorectal Cancer Treatments and Studies (9 papers), Gastrointestinal Tumor Research and Treatment (8 papers), Genetic factors in colorectal cancer (7 papers) and Cancer-related Molecular Pathways (7 papers). The work is most often cited by research in Cancer Research (433 citations), Oncology (600 citations), Molecular Biology (1.2k citations), Biotechnology (96 citations) and Aging (13 citations). Shu Okamura has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Curtis C. Harris, Makoto Nagashima, Koh Miura, Masayuki Shiseki, S. Perwez Hussain, Peijun He, Morito Monden, Hirofumi Arakawa, Yusuke Nakamura and Ching Ching Ng. Their work appears in journals such as Gastric Cancer, International Journal of Oncology, Surgery Today, Cancer Science and International Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.